Skip to content

Development of Yoga Intervention Module for Children and Adolescents with Major Depressive Disorder.

Bichitra Nanda Patra, Rajesh Sagar, Gautam Sharma, Kanika Khandelwal, Ruchi Goswami

International Journal of Yoga 2025 DOI: 10.4103/ijoy.ijoy_226_24 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Pilot study Peer reviewed
Sample size 5
Population Children and adolescents with major depressive disorder
Intervention Yoga therapy
Topics Depression
Keywords Adolescents Validation Yoga
Key points Yoga therapy was acceptable among children and adolescents with major depressive disorder, with high compliance and reported reduction in depression scores.

Abstract

Mental health problems constitute around 7.5% of the global burden of disease. Worldwide, depression has been expected to be the second-leading cause of disability by 2020. Child and adolescent depression are associated with decreased school attendance, poor performance at school, use of drugs and alcohol, violence, and suicidal behavior. In recent times, various complementary and alternative medicines (CAMs) such as mindfulness and meditation intervention, acupuncture, nutraceuticals, and physical exercise have also gained interest with encouraging results. One such CAM intervention is Yoga. The current paper focused on the development and validation of yoga therapy. A yoga module was developed in three steps. The first step was the development of a yoga module where traditional texts, research papers were extensively reviewed. Based on that existing literature, a module was outlined. In the second step, the detailed module was validated by the experts in the field of yoga. In the third step, a pilot study was carried out on five participants and they were administered on depression scale for children. Moreover caregivers were also assessed on variables like depression, stress and anxiety at baseline and postassessment. It was found that yoga therapy was acceptable among children and adolescents with major depressive disorder. There was high compliance among participants. They reported overall satisfaction and found a reduction in depression scores on the measures used. Yoga therapy should be recommended by professionals in out-patient clinics. Moreover, this is a pilot-tested study and hence comment on the efficacy of the present study could not be made.

Comparable studies

Other non-randomized and open-label trials on depression, most cited first.

Study Year Design Participants
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Patients with moderate-to-severe, unipolar, treatment-resistant major depression 2016 Open-label feasibility trial n = 12
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Patients with severe, unipolar, treatment-resistant major depression 2017 Open-label trial n = 20
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression 2018 Clinical trial n = 20
Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder Subjects with DSM-IV-diagnosed treatment-resistant major depressive disorder 2010 Open-label trial n = 33
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression Patients with recurrent depression 2015 Open-label trial n = 17

Citations in the library

Explore topics